a2 Milk Co. Secures Early Regulatory Approvals to Progress China-Label Formula

MT Newswires Live
2025/11/24

a2 Milk Co. (NZE:ATM, ASX:A2M) secured early approvals from New Zealand's Ministry for Primary Industries and China's General Administration of Customs to transition two infant milk formula products acquired with the a2 Pokeno facility to the company-branded products, according to a Monday filing with the Australian and New Zealand bourses.

The final step involves submitting for approval from the State Administration for Market Regulation, scheduled for December, with the review process anticipated to take around six months, per the filing.

The company remains on track to launch the new products in the late first half of 2027, the filing added.

The company's New Zealand shares shed about 2% in recent Monday trade.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10